Breaking Point? The Cost of Oncology Care in the U.S.

Published on: July 21, 2014

Pharmaceutical Executive

The US healthcare system is expected to spend more than $150 billion treating cancer by 2020.

The US healthcare system is expected to spend more than $150 billion treating cancer by 2020. In this PharmExec article, Daniele Severi Bruni, Jacob J. Schutz, and Anthony Hewitt of Icon plc ask if we have we have hit a breaking point in the escalating cost of oncology care.